Skip to main content

Table 1 Comparison of demographic profile and serological testing between HIV/AIDS patients with and without CMV colitis

From: Programmed death-1 expression and regulatory T cells increase in the Intestinal mucosa of cytomegalovirus colitis in patients with HIV/AIDS

  HIV+ CMV (CMV colitis group, n = 20) (mean ± SD; Median; IQR) HIV (control group, n = 175) (mean ± SD; Median; IQR) Total P value
Sex
 Male 18 (90%) 155 (88.6%) 173 (88.7%) 0.848
 Female 2 (10%) 20 (11.4%) 22 (11.3%)
Age (year)
 Average 39.1 ± 11.2; 41; 27–51 37.9 ± 11.6; 35; 29–46 38.0 ± 11.6;36; 29–46 0.666
 Serum CD4+ T cells (cells/μL) 31.3 ± 40.3; 14; 5–46 210.6 ± 217.1; 140.5; 24.5–345.5; < 0.001
 Serum CD8+ T cells (cells/μL) 531.6 ± 500.6; 468; 123–682 746.3 ± 543.1; 617.5; 386.25–918.75 0.102
 Leukocyte (109/L) 5.08 ± 4.51; 3.77; 2.25–5.39 5.21 ± 2.61; 4.84; 3.245–6.475 0.902
 Erythrocyte (1012/L) 2.91 ± 0.54; 2.81; 2.47–3.4 3.71 ± 0.96; 3.74; 2.97–4.47 < 0.001
 Hemoglobin (g/L) 87.3 ± 17.9; 88.4; 72.2–107 115.7 ± 30.7; 115; 94–141.1 < 0.001
 Platelet (109/L) 189.4 ± 120.3; 173; 118–221.8 207.9 ± 83.5; 205.5; 154.95–261.5 0.385
 HIV viral load (copies/mL) 261,939 ± 241,476; 302,918; 53,904–387,750 337,875 ± 971,601; 90,565.5; 11,341.25–441,623 0.764
\